May 23, 2019
Targovax announces median and three-year overall survival for TG01 trial in resected pancreatic cancer
Media
May 23, 2019
Nordic Nanovector ASA – Results for the First Quarter 2019
May 21, 2019
MIPS acquires patent rights and the brand FLUID
May 21, 2019
Nordic Nanovector: Archer-1 phase 1b Betalutin®/rituximab combination trial advances to next cohort
May 21, 2019
CERAMENT® – Now Available Exclusively Through BONESUPPORT
May 21, 2019
Interim Report Q1 2019
May 20, 2019
Rainier Therapeutics Announces Presentation of Patient Biopsy Data Demonstrating Vofatamab’s Ability to Increase Immune Cell Activation
May 20, 2019
Oncopeptides to Apply for Accelerated Approval in the US
May 17, 2019
Camel-IDS appoints Thomas Ramdahl as Independent Director
May 16, 2019
Oncopeptides Announces Acceptance of Four Abstracts Highlighting Melflufen Clinical Programs for Presentation at 24th EHA Congress in June 2019